24.08.2022
DNA-Stränge
Event Note

2nd Gene Therapy Forum: Challenges and Opportunities in Rare Genetic Diseases on September 17

On Saturday, September 17, 2022, Pfizer Pharma GmbH will host the 2nd Gene Therapy Forum. The virtual event is explicitly aimed at medical professionals. CME certification has been applied for.

This year, the focus will be on the following topics:

  • What are the challenges in finding a diagnosis for rare genetic diseases?
  • What factors can determine the success of gene therapy?

Interested medical professionals are cordially invited to join in the discussion and ask their questions.

Registration

Program

9.00 a.m.

Welcome and introduction to the topic

  • Prof. Dr. Hildegard Büning f
  • Prof. Dr. Andreas Tiede, Medizinische Hochschule Hannover

Session 1: Diagnosis of rare diseases: An interdisciplinary challenge?

9.05 a.m. - Preamble

  • Prof. Dr. Hildegard Büning, Medizinische Hochschule Hannover

09.10 a.m. - Role of the Centers for Rare Diseases

  • Dr. Holm Graessner, ZSE Tübingen

9.40 a.m. - From suspicion to diagnosis

  • Prof. Dr. Stefan Mundlos, Charité – Universitätsmedizin Berlin

10.10 a.m. - Discussion Session 1

  • Prof. Dr. Hildegard Büning, Medizinische Hochschule Hannover

10.20 a.m. - Coffee break

Session 2: What does successful gene therapy depend on?

10.30 a.m. - Introduction

  • Prof. Dr. Andreas Tiede, Medizinische Hochschule Hannover

10.35 a.m. - Immunologic aspects

  • Prof. Dr. Ulrike Köhl, Medizinische Hochschule Hannover

11.05 a.m. - Interdisciplinary collaboration

  • Prof. Dr. Ulrike Schara-Schmidt, Universitätsmedizin Essen

11.35 a.m. - Discussion: Session 2

  • Prof. Dr. Andreas Tiede, Medizinische Hochschule Hannover

11.45 a.m. - Summary, learning success control and farewell

  • Prof. Dr. Hildegard Büning und Prof. Dr. Andreas Tiede, Medizinische Hochschule Hannover

12.00 p.m. - End

Host: Pfizer Pharma GmbH - Linkstraße 10 - 10785 Berlin


Newsletter subscription
Our free newsletter informs you four times a year about current calls for proposals, events and projects on rare diseases.